EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Microbial modulation as a game changer: Boosting immunotherapy efficacy in breast cancer

Fada Xia, Qiaoli Yi, Zhijie Xu, Zhiyang Zhou, Hailin Tang, Kejing Zhang, Yuanliang Yan

Seminars in Cancer Biology · 2025

DOI: 10.1016/j.semcancer.2025.10.006 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2025. Verfasst von Fada Xia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid Surgery, Xiangya Hospital, Central South University, Changsha, Hunan 410000, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Immunotherapy, Gastrointestinal Microbiome, Microbiota. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 161 Literaturangaben. Gefördert von: Wu Jieping Medical Foundation, National Natural Science Foundation of China, Hunan Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is generally regarded as an immunologically cold tumor, characterized by limited T cell infiltration and poor responsiveness to immune checkpoint inhibitors. Increasing evidence suggests that the human microbiome, including both gut and tumor-associated microbial communities, serves as a critical regulator of systemic and local antitumor immunity, with potential to convert inert tumors into immune-responsive states. Gut microbiota influence systemic immune homeostasis through metabolites such as lipids, lactic acid, and trimethylamine N-oxide, which modulate T lymphocytes, dendritic cells, leukocytes, and stromal components. Tumor-resident microbiota further shape the tumor immune microenvironment by regulating CD4⁺ and CD8⁺ T cells, NKT cells, Tregs, and macrophages, thereby impacting the efficacy of immune checkpoint blockade. Emerging strategies to sensitize cold breast tumors through microbiome modulation include dietary phytochemicals, bariatric surgery induced microbial shifts, probiotics and postbiotics, polyvalent microbial antigen vaccines, and nanotechnology-based platforms. Clinical challenges remain, particularly interindividual microbial heterogeneity, safety and regulatory considerations, and the need for reliable microbial and immune biomarkers. This review summarizes current advances in microbiota-immune interactions in breast cancer and discusses opportunities for microbiome-targeted strategies to enhance immunotherapy outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsImmunotherapyGastrointestinal MicrobiomeMicrobiotaHumansFemaleTumor MicroenvironmentAnimalsProbiotics

Stichwörter der Autor:innen

Breast cancerImmunotherapyMicrobiomeTherapeutic strategies

Autor:innen und Institutionen

  • Department of Thyroid Surgery, Xiangya Hospital, Central South University, Changsha, Hunan 410000, China.
  • Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
  • Department of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
  • State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong 510060, China.
  • Department of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China. Electronic address: ZKJ5073@csu.edu.cn.
  • Department of Pharmacy, The Hunan Institute of Pharmacy Practice and Clinical Research, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; National Clinical Research Center for Geriatric Disorder…

Förderung

  • Wu Jieping Medical Foundation
  • National Natural Science Foundation of China
  • Hunan Provincial Natural Science Foundation

Zitieren

APA

Xia, F., Yi, Q., Xu, Z., Zhou, Z., Tang, H., Zhang, K., & Yan, Y. (2025). Microbial modulation as a game changer: Boosting immunotherapy efficacy in breast cancer. Seminars in Cancer Biology. https://doi.org/10.1016/j.semcancer.2025.10.006

Vancouver

Xia F, Yi Q, Xu Z, Zhou Z, Tang H, Zhang K, et al. Microbial modulation as a game changer: Boosting immunotherapy efficacy in breast cancer. Seminars in Cancer Biology. 2025. doi:10.1016/j.semcancer.2025.10.006

BibTeX
@article{Xia2025,
  author = {Xia, Fada and Yi, Qiaoli and Xu, Zhijie and Zhou, Zhiyang and Tang, Hailin and Zhang, Kejing and Yan, Yuanliang},
  title = {Microbial modulation as a game changer: Boosting immunotherapy efficacy in breast cancer},
  journal = {Seminars in Cancer Biology},
  year = {2025},
  doi = {10.1016/j.semcancer.2025.10.006}
}
Kostenlos starten →